Lexeo Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 6.38 M | $29.72 M | 410.74% | 7.46% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 5.81 M | $27.03 M | 15.00% | 6.78% |
| BLACKROCK, INC. | 08/07/2026 | 5.74 M | $26.72 M | 12.30% | 6.70% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 5.00 M | $23.28 M | 0.00% | 5.84% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 4.82 M | $22.46 M | 9.04% | 5.63% |
| STATE STREET CORP | 08/07/2026 | 4.35 M | $20.27 M | 22.04% | 5.09% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 4.32 M | $20.11 M | -3.46% | 5.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 4.18 M | $19.44 M | -32.48% | 4.88% |
| JUPITER TOPCO LLC | 08/14/2026 | 3.95 M | $18.41 M | 100.00% | 4.62% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 3.95 M | $18.38 M | 9.59% | 4.61% |
| CITADEL ADVISORS LLC | 09/02/2026 | 3.90 M | $18.15 M | 1.66% | 4.55% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.13 M | $14.55 M | 3.95% | 3.65% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.83 M | $13.19 M | 75.70% | 3.31% |
| WOODLINE PARTNERS LP | 08/14/2026 | 2.50 M | $11.64 M | -9.09% | 2.92% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 2.41 M | $11.23 M | 51.78% | 2.82% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.15 M | $10.01 M | 10.24% | 2.51% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.88 M | $8.73 M | 56.25% | 2.19% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.75 M | $8.14 M | 15.47% | 2.04% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.57 M | $7.29 M | 6.72% | 1.83% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 1.49 M | $6.93 M | -20.58% | 1.74% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 1.38 M | $6.41 M | 195.63% | 1.61% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.30 M | $6.05 M | 8.33% | 1.52% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.29 M | $5.99 M | 16.64% | 1.50% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 928.59 K | $4.32 M | 0.00% | 1.08% |
| BLACKSTONE INC. | 08/14/2026 | 904.96 K | $4.22 M | 0.00% | 1.06% |
| NORTHERN TRUST CORP | 08/13/2026 | 867.39 K | $4.04 M | 75.70% | 1.01% |
| ABRDN PLC | 07/31/2026 | 675.09 K | $3.14 M | 174.53% | 0.79% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 613.83 K | $2.86 M | 6.35% | 0.72% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 513.01 K | $2.39 M | 0.00% | 0.60% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 490.33 K | $2.28 M | -0.24% | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 430.70 K | $2.00 M | 11.95% | 0.50% |
| MORGAN STANLEY | 08/13/2026 | 395.10 K | $1.84 M | -1.94% | 0.46% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 388.40 K | $1.81 M | 70.20% | 0.45% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 377.06 K | $1.76 M | 0.00% | 0.44% |
| UBS GROUP AG | 08/13/2026 | 354.04 K | $1.65 M | 10.04% | 0.41% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 314.89 K | $1.47 M | 100.00% | 0.37% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 294.77 K | $1.37 M | -7.62% | 0.34% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 265.70 K | $1.24 M | 100.00% | 0.31% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 256.66 K | $1.19 M | -24.43% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 250.37 K | $1.17 M | 100.00% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 202.38 K | $942.09 K | 17.19% | 0.24% |
| NUVEEN, LLC | 08/11/2026 | 200.42 K | $932.94 K | 9.53% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 183.88 K | $855.98 K | 15.72% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 172.61 K | $803.50 K | -5.20% | 0.20% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 172.61 K | $803.50 K | 100.00% | 0.20% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 161.06 K | $749.74 K | 42.56% | 0.19% |
| PRIVIUM FUND MANAGEMENT B.V. | 08/07/2026 | 155.00 K | $722.30 K | -24.39% | 0.18% |
| XTX TOPCO LTD | 08/14/2026 | 145.56 K | $677.56 K | 44.68% | 0.17% |
| FMR LLC | 08/13/2026 | 141.15 K | $657.04 K | 478.75% | 0.16% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 136.38 K | $634.84 K | 0.00% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexeo Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 177 institutional investors and hedge funds held shares of Lexeo Therapeutics Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 6.38 M
Affinity Asset Advisors, LLC: 5.81 M
BlackRock, Inc.: 5.74 M
RA CAPITAL MANAGEMENT, L.P.: 5 M
Frazier Life Sciences Management, L.P.: 4.82 M
STATE STREET CORP: 4.35 M
103.26% of Lexeo Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 98.26 M shares in the last 24 months. This purchase volume represents approximately $731.05 M in transactions.